• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Case Report Documents Delayed Hypertensive Uveitis Following Faricimab Eye Injections

by
November 19, 2026
in Health
Reading Time: 2 mins read
0
Case Report Documents Delayed Hypertensive Uveitis Following Faricimab Eye Injections

Case Report Documents Delayed Hypertensive Uveitis Following Faricimab Eye Injections

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective clinical case report documents the emergence of delayed-onset hypertensive uveitis in a patient following repeated intravitreal injections of the bispecific antibody faricimab. Ten days after receiving her seventh faricimab injection, the patient presented with vision loss, mild eye pain, elevated intraocular pressure, unilateral granulomatous anterior and intermediate uveitis, and distinctive mutton-fat keratic precipitates. The clinical observation contributes new documentation to real-world safety monitoring for the medication, which has seen increasing documentation of associated intraocular inflammation in recent large clinical cohorts.

Faricimab is a humanized, bispecific monoclonal antibody designed to bind and inhibit both angiopoietin-2 and all vascular endothelial growth factor-A isoforms. Regulatory authorities have approved the therapeutic agent for treating neovascular age-related macular degeneration, diabetic macular oedema, and retinal vein occlusion.

To investigate the clinical course of the complication, investigators conducted a retrospective chart review extracting clinical data, multimodal imaging, and serial slit-lamp photography from the affected patient. The medical team applied the Standardization of Uveitis Nomenclature criteria to systematically grade the severity and location of the intraocular inflammation. Additionally, evaluators utilized the standardized Naranjo Probability Scale to formally assess the likelihood that the observed inflammatory episode represented an adverse drug reaction.

A primary novel contribution of the clinical report centers on the detailed serial photographic documentation tracking the morphological evolution and eventual resolution of the granulomatous keratic precipitates over a five-month follow-up period. The patient was successfully managed using a medical regimen consisting of topical corticosteroids alongside hypotensive eye drops, ultimately achieving complete clinical resolution of the inflammatory signs and elevated pressure.

Despite the probable attribution to faricimab therapy, the authors highlighted a significant diagnostic limitation in the retrospective review. Aqueous humor viral testing was not performed during the patient’s acute presentation, leaving a viral infectious etiology as an unexcluded alternative diagnosis that could mimic similar ocular findings.

The authors concluded that while this observation highlights a potential risk of delayed-onset intraocular inflammation, infectious etiologies must be strictly evaluated before definitively attributing such events to the therapeutic agent. The findings emphasize the vital importance of ongoing monitoring, careful diagnostic workups, and continued research into the real-world safety characteristics of faricimab in clinical ophthalmology practice.

Subject of Research: Faricimab-associated hypertensive uveitis case report and clinical evaluation

Article Title: Faricimab-associated hypertensive uveitis – a case report

Article References: Nastasi, A., Vinciguerra, R., & Romano, M. R. (2026). Faricimab-associated hypertensive uveitis – a case report. Journal of Ophthalmic Inflammation and Infection. https://doi.org/10.1186/s12348-026-00635-5

Image Credits: AI Generated

DOI: 10.1186/s12348-026-00635-5

Keywords: faricimab, hypertensive uveitis, intraocular inflammation, keratic precipitates, ophthalmology, adverse drug reaction, mutton-fat keratic precipitates, retinal vein occlusion, diabetic macular oedema, neovascular age-related macular degeneration, angiopoietin-2, VEGF-A, Naranjo Probability Scale, Standardization of Uveitis Nomenclature, corticosteroids, intraocular pressure

News Source: Ophelia Keating. (November 19, 2026). Case Report Documents Delayed Hypertensive Uveitis Following Faricimab Eye Injections. Scienmag.

Tags: adverse drug reactionAngiopoietin-2corticosteroidsdiabetic macular oedemafaricimabhypertensive uveitisintraocular inflammationintraocular pressurekeratic precipitatesmutton-fat keratic precipitatesNaranjo probability scaleneovascular age-related macular degenerationOphthalmologyretinal vein occlusionStandardization of Uveitis NomenclatureVEGF-A
Share12Tweet7Share2ShareShareShare1

Related Posts

Repeated COVID-19 Boosters Preserve Long-Term Memory B Cells in Vulnerable Nursing Home Residents

Repeated COVID-19 Boosters Preserve Long-Term Memory B Cells in Vulnerable Nursing Home Residents

November 19, 2026
Uzbekistan Study Links Household Hygiene Sharing to Hepatitis D Infection

Uzbekistan Study Links Household Hygiene Sharing to Hepatitis D Infection

November 19, 2026

Chronic Jet Lag Disrupts Molecular Brain Clocks and Kynurenine Metabolism in Rats

November 19, 2026

Single-Dose PCV20 Vaccination Proves Cost-Effective for Vulnerable Adults in India

November 19, 2026

POPULAR NEWS

  • Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    29 shares
    Share 12 Tweet 7
  • Industrial Winemaking Enzyme Cocktail Enables High Efficiency Genetic Transformation in Medicinal Mushrooms

    29 shares
    Share 12 Tweet 7
  • Infantile Case Report Links Novel NAXE Gene Variant to Fatal Encephalopathy

    29 shares
    Share 12 Tweet 7
  • Inherited Genetic Variants Significantly Shape Glioma Risk and Tumor Biology

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Repeated COVID-19 Boosters Preserve Long-Term Memory B Cells in Vulnerable Nursing Home Residents

Uzbekistan Study Links Household Hygiene Sharing to Hepatitis D Infection

Chronic Jet Lag Disrupts Molecular Brain Clocks and Kynurenine Metabolism in Rats

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.